Less Ads, More Data, More Tools Register for FREE

Pin to quick picksESKN.L Regulatory News (ESKN)

  • There is currently no data for ESKN

Disposal

20 Jun 2023 07:00

RNS Number : 2313D
Esken Limited
20 June 2023
 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

20 June 2023

ESKEN LIMITED

("Esken", the "Group" or the "Company")

 

Sale of investment in Mersey Bioenergy

 

Esken, the aviation and renewable energy group, announces that its wholly owned subsidiary, Esken Green Energy Limited, has today agreed the sale of its investment in Mersey Bioenergy Holdings Limited and its wholly owned subsidiary (together "Mersey Bioenergy") to UK Waste Resources and Energy Investments L.P., a member of the Bioenergy Infrastructure Group, for a total cash consideration of £9m (the "Disposal").

 

Mersey Bioenergy owns and operates a combined heat and power plant in Widnes and the Disposal is part of Esken's ongoing strategy to dispose of non-core assets.

 

Esken's investment in Mersey Bioenergy comprised a 39.6% shareholding and £7.3m of unsecured 13.5% loan notes with a ten-year term ending in November 2024. The shareholding and loan notes had been fully written down by Esken, with a £nil net book value as at 31 August 2022, and the investment in Mersey Bioenergy did not contribute to either profit or loss for the Group in the year ended 28 February 2022.

 

The consideration of £9m will be paid in cash on completion, and the cash will be used for repayment of debt and working capital purposes. Completion will take place once certain conditions have been satisfied, including conditions which relate to the refinancing of Mersey Bioenergy by Bioenergy Infrastructure Group and the capitalisation of all existing loan notes issued by Mersey Bioenergy Holdings Limited. Completion is expected to take place before the end of August 2023.

 

This Disposal does not impact the Mersey Bioenergy Fuel Supply Agreement with Esken Renewables, which expires July 2035.

 

Additional information

 

The Disposal constitutes a Class 2 transaction for Esken for the purposes of the Financial Conduct Authority's Listing Rules.

 

The current shareholders in Mersey Bioenergy Holdings Limited are: UK Waste Resources and Energy Investments L.P. (49.9%), Esken Green Energy Limited (39.6%) and Burmeister & Wain Scandinavian Contractor A/S (10.5%).

 

Enquiries:

Esken Limited C/o Tulchan Communications

Charlie Geller, Group Communications DirectorTulchan Communications

Olivia Peters / Lisa Jarrett-Kerr

020 7353 4200

esken@tulchangroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISUKVUROSUNAUR
Date   Source Headline
21st Dec 20224:35 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20224:35 pmRNSPrice Monitoring Extension
8th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:36 pmRNSPrice Monitoring Extension
29th Nov 20221:49 pmRNSResult of EGM
24th Nov 20224:35 pmRNSPrice Monitoring Extension
10th Nov 20227:00 amRNSTR-1
9th Nov 20227:00 amRNSInterim Results
9th Nov 20227:00 amRNSNotice of EGM
3rd Nov 20227:00 amRNSNotice of Results
19th Oct 202210:18 amRNSTR-1
12th Sep 20224:41 pmRNSSecond Price Monitoring Extn
12th Sep 20224:35 pmRNSPrice Monitoring Extension
12th Sep 202210:53 amRNSListing Rule 9.6.14(2) Disclosure
31st Aug 20227:00 amRNSTrading Statement
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
10th Aug 20224:35 pmRNSPrice Monitoring Extension
5th Aug 202210:59 amRNSTR-1
28th Jul 20224:35 pmRNSPrice Monitoring Extension
13th Jul 20222:43 pmRNSAGM results
5th Jul 20224:35 pmRNSPrice Monitoring Extension
5th Jul 20227:00 amRNSDirector/PDMR Shareholding
30th Jun 20227:00 amRNSAudit tender outcome and annual general meeting
23rd Jun 20224:35 pmRNSPrice Monitoring Extension
17th Jun 20224:41 pmRNSSecond Price Monitoring Extn
17th Jun 20224:37 pmRNSPrice Monitoring Extension
16th Jun 20222:27 pmRNSDirector/PDMR Shareholding
13th Jun 20224:36 pmRNSPrice Monitoring Extension
13th Jun 20223:28 pmRNSPosting of Annual Report and Notice of AGM
10th Jun 20224:36 pmRNSPrice Monitoring Extension
8th Jun 20224:35 pmRNSPrice Monitoring Extension
1st Jun 20224:36 pmRNSPrice Monitoring Extension
27th May 20224:40 pmRNSSecond Price Monitoring Extn
27th May 20224:35 pmRNSPrice Monitoring Extension
25th May 20227:00 amRNSFinal Results
18th May 20221:03 pmRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSNotice of Results
12th May 20224:42 pmRNSSecond Price Monitoring Extn
12th May 20224:36 pmRNSPrice Monitoring Extension
30th Mar 20224:35 pmRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSTrading Statement
11th Mar 20224:35 pmRNSPrice Monitoring Extension
4th Mar 20224:42 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
23rd Feb 20227:00 amRNSAppointment of Joint Broker
18th Feb 20224:40 pmRNSSecond Price Monitoring Extn
18th Feb 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.